You are here
Increased risk of age-related diseases for HIV positive populations
30 September, 2014
Recent studies of older HIV positive people has found that people living with HIV are at greater risk of suffering from age-related diseases than not HIV infected people
PLHIV have lower health quality of life despite treatment
26 September, 2014
People living with HIV (PLHIV) who are on antiretroviral treatment (ART) and have achieved viral suppression, still have a lower health-related quality-of-life (HRQoL) than those in the general population. Data from the UK shows that despite life expectancy for PLHIV nearly equalling the general population, morbidity is still an important issue.
New progresses for infant HIV vaccine development
24 September, 2014
A possible breakthrough in the development of an HIV vaccine for infants has been announced by researches of Duke University.
Global summit focuses on HIV treatment targets as the way forward
19 September, 2014
Ending the AIDS epidemic as a global health threat is possible, and within reach, if resources are pooled effectively according to global leaders, leading academics, policy makers and people in the treatment industry and the HIV community at the annual summit, Controlling the HIV Epidemic with Antiretrovirals
HIV self-testing effective for reaching MSM in China
17 September, 2014
Self-testing for HIV can be an effective way of increasing uptake of HIV testing and reaching high risk sub-groups of men who have sex with men (MSM) in China. An online survey conducted in China, found that 20.3 percent of MSM in the country had self-tested for HIV at least once in their lives.
HIV positive mothers likely to stop treatment after delivery
15 September, 2014
Mothers living with HIV in South Africa often discontinue HIV care after their child is born and has tested negative for HIV, as they perceive their own health as unimportant.
The war on drugs has failed: Global Commission on Drug Policy launches new report
12 September, 2014
The Global Commission on Drug Policy met this week in New York for the launch their new report, Taking Control: pathways to drug policies that work. The report calls on world leaders and policymakers to re-think and reform global drug policy, moving away from the ‘war on drugs’ stance, which they argue has failed, to a stance focused on human rights and access to healthcare.
Visceral leishmaniasis-HIV co-infection an emerging global health issue
10 September, 2014
Visceral leishmaniasis-HIV (VL/HIV) co-infection is an emerging global health issue, prominent in Africa, and on the rise in South America and India. Visceral leishmaniasis (VL) is a disease that develops from the leishmaniasis parasite, which is transmitted via the bite of a sand fly. VL is the biggest global parasite killer after malaria, and is a major concern for people living with HIV (PLHIV) as a potentially life threatening co-infection.